Zhejiang Neo-Dankong Pharmaceutical Company is Pharmaceuticals in China that focus on pharmaceutical drugs business. Founded in 2001. They cover business area such as manufacturer, pharmaceutical drug, infection, anti-, tumor, cardiovascular and nervous system relate disease, patient, chronic illness.
2001
( 25 years old in 2026 )
Pharmaceutical Drugs
-
No. 183, Zhongxin Road
Jiaojiang District
Taizhou City, Zhejiang Province 318000
China
Private
manufacturerpharmaceutical druginfection, anti-tumor, cardiovascular and nervous system relate diseasepatientchronic illness
* We use standard office opening hours in near Zhejiang Neo-Dankong Pharmaceutical Company's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Zhejiang Neo-Dankong Pharmaceutical Company is Pharmaceuticals business from China that founded in 2001 (25 years old in 2026), Zhejiang Neo-Dankong Pharmaceutical Company business is focusing on Pharmaceutical Drugs.
Zhejiang Neo-Dankong Pharmaceutical Company headquarter office and corporate office address is located in No. 183, Zhongxin Road Jiaojiang District Taizhou City, Zhejiang Province 318000 China.
Zhejiang Neo-Dankong Pharmaceutical Company was founded in China.
In 2026, Zhejiang Neo-Dankong Pharmaceutical Company is currently focus on pharmaceutical drugs sector.
Above is snippet of Google Trends for "pharmaceutical drugs" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Zhejiang Neo-Dankong Pharmaceutical Company, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
